Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
SAN DIEGO, Aug. 31, 2011 /PRNewswire/ — Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:
Stifel Nicolaus 2011 Healthcare -- Conference Date: Wednesday, September 7, 2011 1:30pm Eastern Time (10:30am Time: Pacific Time) Place: Four Seasons Hotel in Boston Scott Byrd, SVP & Chief Speaker: Commercial Officer -- UBS Global Life Sciences Conference Date: Tuesday, September 20, 2011 11:30am Eastern Time (8:30am Time: Pacific Time) Grand Hyatt Hotel in New Place: York City Ted Schroeder, President & Speaker: CEO -- JMP Securities Healthcare Conference Wednesday, September 28, Date: 2011 9:30am Eastern Time (6:30am Time: Pacific Time) The St. Regis Hotel in New Place: York City Ted Schroeder, President & Speaker: CEO
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.
Contacts: William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400
SOURCE Cadence Pharmaceuticals, Inc.